Diagnosis, prevalence, and screening of familial dilated cardiomyopathy

Expert Opinion on Orphan Drugs

Volumn 3, Issue 8, 2015, Pages 869-876

  Sweet, Mary E ^a   Taylor, Matthew Rg ^a   Mestroni, Luisa ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiomyopathy; dilated cardiomyopathy; familial; genetic testing

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; COPY NUMBER VARIATION; FAMILIAL DILATED CARDIOMYOPATHY; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC SCREENING; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; PHENOTYPE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 84937469211     PISSN: None     EISSN: 21678707     Source Type: Journal    
DOI: 10.1517/21678707.2015.1057498     Document Type: Review

References (43)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation 2015;131(4):e29-322
2. Fatkin D. Familial dilated cardiomyopathy: Current challenges and future directions. Global Cardiol Sci Pract 2012;2012(1):8
3. Fatkin D; Members of the CCGDCWG. Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart Lung Circ 2011;20(11):691-3
4. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113(14):1807-16
5. Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 2013;10(9):531-47
6. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Col Cardiol 2005;45(7):969-81
7. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Eng J Med 1992;326(2):77-82
8. Grunig E, Tasman JA, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Col Cardiol 1998;31(1):186-94
9. Mestroni L, Maisch B, McKenna WJ, et al. Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the european human and capital mobility project on familial dilated cardiomyopathy. Eur Heart J 1999;20(2):93-102
10. Hershberger RE, Siegfried JD. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Col Cardiol 2011;57(16):1641-9
11. Sinagra G, Mestroni L, Camerini F. Genetic cardiomyopathies: a clinical approach. Springer; Milan, Italy: 2013
12. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 2013;123(1):19-26
13. Teekakirikul P, Kelly MA, Rehm HL, et al. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagnost 2013;15(2):158-70
14. Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007;39(2):91-107
15. Mestroni L, Tharp CA, Sweet ME, et al. Molecular genetics of dilated cardiomyopathy. eLS 2014
16. Taylor MR, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orpha J Rare Dis 2006;1:27
17. Morales A, Cowan J, Dagua J, Hershberger RE. Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail 2008;14(1):37-45
18. Sturm AC, Hershberger RE. Genetic testing in cardiovascular medicine: current landscape and future horizons. Cur Opin Cardiol 2013;28(3):317-25
19. Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart muscle disease study group. J Am Col Cardiol 1999;34(1):181-90
20. Ghosh N, Haddad H. Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy. Cur Opin Cardiol 2011;26(2):155-64
21. Monserrat L, Hermida M, Bouzas B, et al. Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy. Revi Esp De Cardiol 2002;55(7):725-32
22. Jacoby D, McKenna WJ. Genetics of inherited cardiomyopathy. Eur Heart J 2012;33(3):296-304
23. Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy - A Heart Failure Society of America practice guideline. J Card Fail 2009;15(2):83-97
24. Buss SJ, Breuninger K, Lehrke S, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. Eur Heart J Cardiova Imag 2015;16(3):307-15
25. Zecchin M, Di Lenarda A, Gregori D, et al. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? Pacing Clin Electrophysiol 2008;31(3):290-9
26. Fatkin D, Yeoh T, Hayward CS, et al. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy. Circ Cardiov Gen 2011;4(4):342-8
27. Mahon NG, Murphy RT, MacRae CA, et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Int Med 2005;143(2):108-15
28. Moretti M, Merlo M, Barbati G, et al. Prognostic impact of familial screening in dilated cardiomyopathy. Eur J Heart Fail 2010;12(9):922-7
29. Codd MB, Sugrue DD, Gersh BJ, Melton LJ. 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in olmsted county, Minnesota, 1975-1984. Circulation 1989;80(3):564-72
30. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92(4):785-9
31. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol 1992;69(17):1458-66
32. Miura K, Nakagawa H, Morikawa Y, et al. Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 2002;87(2):126-30
33. Williams DG, Olsen EG. Prevalence of overt dilated cardiomyopathy in two regions of England. Br Heart J 1985;54(2):153-5
34. Rakar S, Sinagra G, Di Lenarda A, et al. Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The heart muscle disease study group. Eur Heart J 1997;18(1):117-23
35. Petretta M, Pirozzi F, Sasso L, et al. Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am J Cardiol 2011;108(8):1171-6
36. Mestroni L, Taylor MR. Genetics and genetic testing of dilated cardiomyopathy: a new perspective. Discov Med 2013;15(80):43-9
37. McNair WP, Sinagra G, Taylor MR, et al. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Col Cardiol 2011;57(21):2160-8
38. van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Col Cardiol 2012;59(5):493-500
39. Meune C, Van Berlo JH, Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Eng J Med 2006;354(2):209-10
40. Herman DS, Lam L, Taylor MR, et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 2012;366(7):619-28
41. Ingles J, Zodgekar PR, Yeates L, et al. Guidelines for genetic testing of inherited cardiac disorders. Heart Lung Circ 2011;20(11):681-7
42. Harakalova M, Kummeling G, Sammani A, et al. A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes. Eur J Heart Fail 2015;17(5):484-93
43. Haas J, Frese KS, Peil B, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015;36(18):1123-35